Archrock Inc
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
AROC$27.88-3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | |
| · · Year Ended December 31, | |||||||||
| · · 2023 · 2022 · 2021 | |||||||||
| Cash flows from operating activities: · · · · · · | |||||||||
| Net income | | $104,998 | | $44,296 | | $28,217 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | ||||||
| Depreciation and amortization | | 166,241 | | 164,259 | | 178,946 | |||
| Long-lived and other asset impairment | | 12,041 | | 21,442 | | 21,397 | |||
| Non-cash restructuring charges | | | 221 | | | — | | | — |
| Unrealized change in fair value of investment in unconsolidated affiliate | | | 973 | | | 1,864 | | | — |
| Inventory write-downs | | 545 | | 1,640 | | 997 | |||
| Amortization of operating lease right-of-use assets | | | 3,319 | | | 3,206 | | | 3,880 |
| Amortization of deferred financing costs | | | 5,729 | | | 5,152 | | | 10,127 |
| Amortization of debt premium | | | (2,006) | | | (2,006) | | | (2,006) |
| Amortization of capitalized implementation costs | | | 2,624 | | | 1,984 | | | — |
| Amortization of dedesignated interest rate swap | | | — | | | 410 | | | 863 |
| Interest rate swaps | | — | | 631 | | 3,539 | |||
| Stock-based compensation expense | | 12,998 | | 11,928 | | 11,336 | |||
| Provision for (benefit from) credit losses | | 224 | | 206 | | (90) | |||
| Gain on sale of assets, net | | (10,199) | | (12,396) | | (11,313) | |||
| Gain on sale of business | | | — | | | (28,098) | | | (18,945) |
| Deferred income tax provision | | 35,658 | | 15,229 | | 10,379 | |||
| Amortization of contract costs | | | 21,289 | | | 19,162 | | | 19,990 |
| Deferred revenue recognized in earnings | | | (16,464) | | | (20,956) | | | (10,382) |
| Changes in operating assets and liabilities: | | | | | | | |||
| Accounts receivable, net | | | (9,123) | | | (19,971) | | | 4,445 |
| Inventory | | | 4,189 | | | (10,520) | | | (12,989) |
| Other assets | | | (1,895) | | | (2,653) | | | 635 |
| Contract costs | | | (24,292) | | | (29,575) | | | (16,991) |
| Accounts payable and other liabilities | | | (12,166) | | | 13,529 | | | 5,269 |
| Deferred revenue | | | 15,386 | | | 24,642 | | | 10,217 |
| Other | | | (103) | | | 45 | | | (121) |
| Net cash provided by operating activities | | 310,187 | | 203,450 | | 237,400 | |||
| | | | | | | | | | |
| Cash flows from investing activities: | | | | ||||||
| Capital expenditures | | (298,632) | | (239,867) | | (97,885) | |||
| Proceeds from sale of business | | | — | | | 99,611 | | | 83,345 |
| Proceeds from sale of property, equipment and other assets | | 72,206 | | 20,654 | | 29,562 | |||
| Proceeds from insurance and other settlements | | | 1,222 | | | 3,353 | | | 1,085 |
| Investments in unconsolidated entities | | | (7,287) | | | (14,667) | | | — |
| Net cash provided by (used in) investing activities | | (232,491) | | (130,916) | | 16,107 | |||
| | | | | | | | | | |
| Cash flows from financing activities: | | | | ||||||
| Borrowings of long-term debt | | 802,825 | | 826,733 | | 704,751 | |||
| Repayments of long-term debt | | (767,050) | | (809,983) | | (863,251) | |||
| Payments of debt issuance costs | | (6,031) | | — | | (2,451) | |||
| Payments for settlement of interest rate swaps that include financing elements | | — | | (1,334) | | (4,390) | |||
| Dividends paid to stockholders | | (95,796) | | (90,315) | | (89,343) | |||
| Net proceeds from issuance of common stock | | | — | | | 4,176 | | | 3,401 |
| Repurchases of common stock | | | (8,860) | | | — | | | — |
| Taxes paid related to net share settlement of equity awards | | | (3,829) | | | (2,447) | | | (2,465) |
| Proceeds from stock issued under ESPP | | 817 | | 633 | | 713 | |||
| Net cash used in financing activities | | (77,924) | | (72,537) | | (253,035) | |||
| Net increase (decrease) in cash and cash equivalents | | (228) | | (3) | | 472 | |||
| Cash and cash equivalents, beginning of period | | 1,566 | | 1,569 | | 1,097 | |||
| Cash and cash equivalents, end of period | | $1,338 | | $1,566 | | $1,569 | |||
| | | | | | | | | | |
| Supplemental disclosure of cash flow information: · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Interest paid | | $107,765 | | $98,406 | | $100,002 | |||
| Income taxes paid, net | | | (1,311) | | | (407) | | | (247) |
| | | | | | | | | | |
| Supplemental disclosure of non-cash investing and financing transactions: | | | | | | | | | |
| Accrued capital expenditures | | $25,689 | | $9,899 | | $7,641 | |||
ARCHROCK, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.